Table of Content


Introduction
Neuroblastoma- Overview
Neuroblastoma- Therapeutics Development
Neuroblastoma- Therapeutics Assessment
Neuroblastoma- Companies Involved in Therapeutics Development
Neuroblastoma- Drug Profiles
Neuroblastoma- Dormant Projects
Neuroblastoma- Discontinued Products
Neuroblastoma- Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Neuroblastoma, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Neuroblastoma, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Neuroblastoma - Pipeline by Ability Pharmaceuticals SL, H2 2020
Neuroblastoma - Pipeline by Actuate Therapeutics Inc, H2 2020
Neuroblastoma - Pipeline by ADC Therapeutics SA, H2 2020
Neuroblastoma - Pipeline by Adicet Bio Inc, H2 2020
Neuroblastoma - Pipeline by Advanced Accelerator Applications SA, H2 2020
Neuroblastoma - Pipeline by Alissa Pharma, H2 2020
Neuroblastoma - Pipeline by Allarity Therapeutics A/S, H2 2020
Neuroblastoma - Pipeline by APEIRON Biologics AG, H2 2020
Neuroblastoma - Pipeline by Aptorum Group Ltd, H2 2020
Neuroblastoma - Pipeline by AstraZeneca Plc, H2 2020
Neuroblastoma - Pipeline by AUM Biosciences Pte Ltd, H2 2020
Neuroblastoma - Pipeline by Autolus Therapeutics Plc, H2 2020
Neuroblastoma - Pipeline by Bayer AG, H2 2020
Neuroblastoma - Pipeline by Bellicum Pharmaceuticals Inc, H2 2020
Neuroblastoma - Pipeline by Bexion Pharmaceuticals LLC, H2 2020
Neuroblastoma - Pipeline by Bio-Cancer Treatment International Ltd, H2 2020
Neuroblastoma - Pipeline by BioEclipse Therapeutics Inc, H2 2020
Neuroblastoma - Pipeline by Biogenera SpA, H2 2020
Neuroblastoma - Pipeline by BioLineRx Ltd, H2 2020
Neuroblastoma - Pipeline by BioVec Pharma Inc, H2 2020
Neuroblastoma - Pipeline by Boehringer Ingelheim International GmbH, H2 2020
Neuroblastoma - Pipeline by Bristol-Myers Squibb Co, H2 2020
Neuroblastoma - Pipeline by Cancer Prevention Pharmaceuticals Inc, H2 2020
Neuroblastoma - Pipeline by Cebiotex SL, H2 2020
Neuroblastoma - Pipeline by Celldex Therapeutics Inc, H2 2020
Neuroblastoma - Pipeline by Cellectar Biosciences Inc, H2 2020
Neuroblastoma - Pipeline by Chiome Bioscience Inc, H2 2020
Neuroblastoma - Pipeline by Clarity Pharmaceuticals Pty Ltd, H2 2020
Neuroblastoma - Pipeline by Cleveland BioLabs Inc, H2 2020
Neuroblastoma - Pipeline by CorMedix Inc, H2 2020
Neuroblastoma - Pipeline by Curis Inc, H2 2020
Neuroblastoma - Pipeline by Cyclacel Pharmaceuticals Inc, H2 2020
Neuroblastoma - Pipeline by DEKK-TEC Inc, H2 2020
Neuroblastoma - Pipeline by Eli Lilly and Co, H2 2020
Neuroblastoma - Pipeline by Epigene Therapeutics Inc, H2 2020
Neuroblastoma - Pipeline by Epizyme Inc, H2 2020
Neuroblastoma - Pipeline by Errant Gene Therapeutics LLC, H2 2020
Neuroblastoma - Pipeline by EUSA Pharma (UK) Ltd, H2 2020
Neuroblastoma - Pipeline by Expression Therapeutics LLC, H2 2020
Neuroblastoma - Dormant Projects, H2 2020
Neuroblastoma - Discontinued Products, H2 2020